CHUK and cancer: The NFkB pathway, a regulator of immune and inflammatory responses (Liu et al., 2017), also implicated in cancer cell proliferation, survival, angiogenesis and plasticity (reviewed in Xia et al., 2014), was downregulated at the level of NFkB (NFKB1) itself and IKK kinase (CHUK).